Calidi Biotherapeutics, Inc. (CLDI) Total liabilities

Calidi Biotherapeutics, Inc. (CLDI) total liabilities at each fiscal year-end, per SEC filings.

$43.4MFY2023

Fiscal year	Value	YoY
FY2023	$43.4M	—

Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.

Source: SEC XBRL filings · For reference only · Not investment advice

More CLDI financial trends

CLDI Revenue CLDI Net income CLDI Net margin CLDI Gross profit CLDI Gross margin CLDI Operating income CLDI Operating margin CLDI Operating cash flow CLDI Free cash flow CLDI Capital expenditures CLDI Return on equity CLDI Stock buybacks CLDI Dividends paid CLDI Total assets CLDI Shareholders’ equity CLDI overview →